a significant reduction of the total seizure number was observed in the progabide period as compared with the placebo period , both in the whole patient group ( p less than 0.01 ) and in the two subgroups of patients with generalized ( p less than 0.01 ) and partial ( p less than 0.05 ) epilepsies .
C0036572
seizure
C0014544
epilepsies